Intuitive Surgical price to free cash flow ISRG
Market value divided by free cash flow over the last twelve months, since 2010.
- Today, Oct 23, 2026
- n/m
- a quarter missing
- 10-year median
- 65.4×
- 10-year range
- 25.5× to 441×
- Peer median
- 22.1×
Intuitive Surgical's price to free cash flow can't be checked today: its free cash flow for Q3 FY26, the quarter to Sep 30, 2026, is missing from our data, so the twelve months it rests on can't be added up.
On the days it had one over the last ten years, its median was 65.4×, from 25.5× in Nov 2016 to 441× in Oct 2024.
Price to free cash flow over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 49.6× | 37.0× | 91.5× |
| 2025 | 90.2× | 77.2× | 360× |
| 2024 | 325× | 90.3× | 441× |
| 2023 | 94.5× | 72.5× | 123× |
| 2022 | 87.2× | 47.7× | 89.5× |
| 2021 | 68.1× | 61.0× | 97.4× |
| 2020 | 97.3× | 39.0× | 97.3× |
| 2019 | 66.2× | 53.8× | 67.9× |
| 2018 | 53.8× | 44.3× | 63.4× |
| 2017 | 42.6× | 26.1× | 46.5× |
| 2016 | 26.0× | 25.5× | 38.0× |
| 2015 | 36.7× | 28.4× | 37.3× |
| 2014 | 30.5× | 19.9× | 30.6× |
| 2013 | 20.6× | 19.1× | 34.5× |
| 2012 | 25.1× | 25.1× | 38.8× |
| 2011 | 36.5× | 24.7× | 37.7× |
| 2010 | 23.8× | 22.9× | 38.8× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Intuitive Surgical's size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| ISRGIntuitive Surgical | n/m |
| BDXBecton, Dickinson and | 19.8× |
| MDLNMedline | n/m |
| RMDResMed | 22.1× |
| WSTWest Pharmaceutical Services | 63.2× |
| Peer median | 22.1× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on Intuitive Surgical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.